Learn how to use your RESPIMAT inhaler.

  • 1 Preparing your RESPIMAT inhaler
  • 2 Using RESPIMAT every day
Close

Answers to Common Questions

It is difficult to insert the cartridge deep enough: Did you accidentally turn the clear base before inserting the cartridge?

Open the cap, press the dose-release button, then insert the cartridge. Place the inhaler on a firm surface and push down firmly until it clicks into place.

Did you insert the cartridge with the wide end first?

Insert the cartridge with the narrow end first.

I cannot press the dose-release button: Did you turn the clear base?

If not, turn the clear base in a continuous movement until it clicks (half a turn).

Is the dose indicator on the COMBIVENT RESPIMAT pointing to zero?

The COMBIVENT RESPIMAT inhaler is locked after 120 puffs (120 doses). If you have a sample, the COMBIVENT RESPIMAT inhaler is locked after 60 puffs (60 doses). Prepare and use your new COMBIVENT RESPIMAT inhaler.

I cannot turn the clear base: Did you turn the clear base already?

If the clear base has already been turned, follow steps "Open" and "Press" under "Daily use" to get your medicine.

The dose indicator on the COMBIVENT RESPIMAT reaches zero too soon: Did you use COMBIVENT RESPIMAT as indicated (1 puff four times daily)?

COMBIVENT RESPIMAT will deliver 120 puffs and last 30 days if used at 1 puff four times daily. If you have a sample, COMBIVENT RESPIMAT will deliver 60 puffs and last 15 days if used at 1 puff four times daily.

Did you turn the clear base before you inserted the cartridge?

The dose indicator counts each turn of the clear base regardless of whether a cartridge has been inserted or not.

Did you spray in the air often to check whether the COMBIVENT RESPIMAT is working?

Once you have prepared COMBIVENT RESPIMAT, no test-spraying is required if used daily.

Did you insert the cartridge into a used COMBIVENT RESPIMAT?

Always insert a new cartridge into a NEW COMBIVENT RESPIMAT.

My COMBIVENT RESPIMAT sprays automatically:
Was the cap open when you turned the clear base?

Close the cap, then turn the clear base.

Did you press the dose-release button when turning the clear base?

Close the cap, so the dose-release button is covered, then turn the clear base.

Did you stop when turning the clear base before it clicked?

Turn the clear base in a continuous movement until it clicks (half a turn).

My COMBIVENT RESPIMAT doesn’t spray: Did you insert a cartridge?

If not, insert a cartridge.

Did you repeat Turn, Open, Press (TOP) less than three times after inserting the cartridge?

Repeat Turn, Open, Press (TOP) three times after inserting the cartridge as shown in steps 4 to 6 under “Prepare for first use.”

Is the dose indicator on the COMBIVENT RESPIMAT pointing to 0?

You have used up all your medicine and the inhaler is locked.

 

Close

Additional Information

Use caution and do not spray in your eyes.

The RESPIMAT inhaler must not be disassembled after inserting the cartridge and replacing the clear base.

Protect the RESPIMAT inhaler from freezing.

Do not touch the piercing element inside the base.

Store the RESPIMAT inhaler out of the reach of children.

If your RESPIMAT inhaler has not been used:

  • For more than 3 days, spray 1 puff toward the ground to prepare the inhaler for use.
  • For more than 21 days, repeat the steps from section 2 ("Preparing Your Inhaler for First-Time Use") until a spray is visible. Then, repeat those steps three more times to prepare the inhaler for use.
  • Keep your RESPIMAT cartridge and inhaler out of the reach of children.
Boehringer Ingelheim

Copyright © 2020 Boehringer Ingelheim Pharmaceuticals, Inc.

All rights reserved. (02/20) PC-US-112561

  • 1
    Preparing your RESPIMAT inhaler
  • 2
    Using RESPIMAT every day
Close

Answers to Common Questions

It is difficult to insert the cartridge deep enough: Did you accidentally turn the clear base before inserting the cartridge?

Open the cap, press the dose-release button, then insert the cartridge. Place the inhaler on a firm surface and push down firmly until it clicks into place.

Did you insert the cartridge with the wide end first?

Insert the cartridge with the narrow end first.

I cannot press the dose-release button: Did you turn the clear base?

If not, turn the clear base in a continuous movement until it clicks (half a turn).

Is the dose indicator on the COMBIVENT RESPIMAT pointing to zero?

The COMBIVENT RESPIMAT inhaler is locked after 120 puffs (120 doses). If you have a sample, the COMBIVENT RESPIMAT inhaler is locked after 60 puffs (60 doses). Prepare and use your new COMBIVENT RESPIMAT inhaler.

I cannot turn the clear base: Did you turn the clear base already?

If the clear base has already been turned, follow steps "Open" and "Press" under "Daily use" to get your medicine.

The dose indicator on the COMBIVENT RESPIMAT reaches zero too soon: Did you use COMBIVENT RESPIMAT as indicated (1 puff four times daily)?

COMBIVENT RESPIMAT will deliver 120 puffs and last 30 days if used at 1 puff four times daily. If you have a sample, COMBIVENT RESPIMAT will deliver 60 puffs and last 15 days if used at 1 puff four times daily.

Did you turn the clear base before you inserted the cartridge?

The dose indicator counts each turn of the clear base regardless of whether a cartridge has been inserted or not.

Did you spray in the air often to check whether the COMBIVENT RESPIMAT is working?

Once you have prepared COMBIVENT RESPIMAT, no test-spraying is required if used daily.

Did you insert the cartridge into a used COMBIVENT RESPIMAT?

Always insert a new cartridge into a NEW COMBIVENT RESPIMAT.

My COMBIVENT RESPIMAT sprays automatically:
Was the cap open when you turned the clear base?

Close the cap, then turn the clear base.

Did you press the dose-release button when turning the clear base?

Close the cap, so the dose-release button is covered, then turn the clear base.

Did you stop when turning the clear base before it clicked?

Turn the clear base in a continuous movement until it clicks (half a turn).

My COMBIVENT RESPIMAT doesn’t spray: Did you insert a cartridge?

If not, insert a cartridge.

Did you repeat Turn, Open, Press (TOP) less than three times after inserting the cartridge?

Repeat Turn, Open, Press (TOP) three times after inserting the cartridge as shown in steps 4 to 6 under “Prepare for first use.”

Is the dose indicator on the COMBIVENT RESPIMAT pointing to 0?

You have used up all your medicine and the inhaler is locked.

Close

Additional information

Use caution and do not spray in your eyes.

The RESPIMAT inhaler must not be disassembled after inserting the cartridge and replacing the clear base.

Protect the RESPIMAT inhaler from freezing.

Do not touch the piercing element inside the base.

Store the RESPIMAT inhaler out of the reach of children.

If your RESPIMAT inhaler has not been used:

  • For more than 3 days, spray 1 puff toward the ground to prepare the inhaler for use.
  • For more than 21 days, repeat the steps from section 2 ("Preparing Your Inhaler for First-Time Use") until a spray is visible. Then, repeat those steps three more times to prepare the inhaler for use.
  • Keep your RESPIMAT cartridge and inhaler out of the reach of children.
Boehringer Ingelheim

Copyright © 2020 Boehringer Ingelheim Pharmaceuticals, Inc.

All rights reserved. (02/20) PC-US-112561

Do you take your medication every day?
Get rewarded for it!

RespiPoints™ lets you earn points, track your medication use, and redeem your points for e-gift cards from top retailers like Amazon.com.

Join for free

Restrictions apply, see amazon.com/gc-legal

After preparing your inhaler,
just remember T.O.P. for daily use.

Turn the clear base

Open the cap and close your lips around the mouthpiece

Press the dose-release button
and inhale the mist

RESPIMAT inhaler RESPIMAT inhaler
The only COPD inhaler to be certified by the Arthritis Foundation as an Ease of Use Product

Discover the mist

Your RESPIMAT inhaler helps make the
most of your COMBIVENT treatment.

The only COPD inhaler to be certified by the Arthritis Foundation as an Ease of Use Product The only COPD inhaler to be certified by the Arthritis Foundation as an Ease of Use Product

Designed with you in mind

The COMBIVENT RESPIMAT inhaler was designed to help you breathe in your medicine. It delivers a slow-moving mist that eases the effort to inhale the medicine.

Gets medicine where it needs to go

Even on days when it's difficult to breathe, your COMBIVENT RESPIMAT inhaler helps get the medicine where it needs to go. COMBIVENT RESPIMAT is not for sudden COPD symptoms. Always carry a rescue inhaler.

SEE MORE

Indication for Use and Important Safety Information

COMBIVENT RESPIMAT (ipratropium bromide and albuterol) is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm (airway narrowing) and who require a second bronchodilator.

Important Safety Information

Do not use COMBIVENT RESPIMAT if you are allergic to any of the ingredients in COMBIVENT RESPIMAT or to atropine or other similar drugs.

COMBIVENT RESPIMAT can cause the narrowing of the airways to get worse (paradoxical bronchospasm) which may be life threatening. If this happens, stop taking COMBIVENT RESPIMAT at once and call your doctor or get emergency help.

COMBIVENT RESPIMAT can cause serious heart-related side effects, such as palpitations, chest pain, rapid heart rate, high blood pressure, tremor, or nervousness. Call your doctor if you experience any of these symptoms.

Avoid spraying COMBIVENT RESPIMAT into your eyes. COMBIVENT RESPIMAT may increase eye pressure which may cause or worsen some types of glaucoma. If you have sudden vision changes, eye pain or visual halos, stop taking COMBIVENT RESPIMAT and call your doctor right away.

COMBIVENT RESPIMAT may cause difficulty with urination.

Dizziness and blurred vision may occur with COMBIVENT RESPIMAT. Should you experience these symptoms, use caution when engaging in activities such as driving a car or operating appliances or other machines.

Do not use COMBIVENT RESPIMAT more often than your doctor has directed. Deaths have been reported with similar inhaled medicines in asthma patients who use the medicine too much. Seek medical attention if your treatment with COMBIVENT RESPIMAT becomes less effective for symptomatic relief, your symptoms become worse, and/or you need to use the product more frequently than usual.

Allergic reactions may occur, including itching, swelling of the face, lips, tongue, or throat (involving difficulty in breathing or swallowing), rash, hives, bronchospasm (airway narrowing), or anaphylaxis. Some of these may be serious. If you experience any of these symptoms, stop taking COMBIVENT RESPIMAT at once and call your doctor or get emergency help.

Tell your doctor about all your medical conditions, especially if you have narrow-angle glaucoma, prostate or urinary problems, a history of heart conditions (such as irregular heartbeat, high blood pressure), thyroid disorder, or diabetes. Also tell your doctor if you are pregnant or nursing. Tell your doctor about all medicines you are taking, especially heart medications or drugs to treat depression.

The most common side effects reported with use of COMBIVENT RESPIMAT include infection of the ears, nose, and throat, runny nose, cough, bronchitis, headache, and shortness of breath.

Click here for full Prescribing Information and Patient Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

CL-CBR-100003

Are you new to COMBIVENT RESPIMAT?

SEE MORE

Indication for Use and Important Safety Information

COMBIVENT RESPIMAT (ipratropium bromide and albuterol) is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm (airway narrowing) and who require a second bronchodilator.

Important Safety Information

Do not use COMBIVENT RESPIMAT if you are allergic to any of the ingredients in COMBIVENT RESPIMAT or to atropine or other similar drugs.

COMBIVENT RESPIMAT can cause the narrowing of the airways to get worse (paradoxical bronchospasm) which may be life threatening. If this happens, stop taking COMBIVENT RESPIMAT at once and call your doctor or get emergency help.

COMBIVENT RESPIMAT can cause serious heart-related side effects, such as palpitations, chest pain, rapid heart rate, high blood pressure, tremor, or nervousness. Call your doctor if you experience any of these symptoms.

Avoid spraying COMBIVENT RESPIMAT into your eyes. COMBIVENT RESPIMAT may increase eye pressure which may cause or worsen some types of glaucoma. If you have sudden vision changes, eye pain or visual halos, stop taking COMBIVENT RESPIMAT and call your doctor right away.

COMBIVENT RESPIMAT may cause difficulty with urination.

Dizziness and blurred vision may occur with COMBIVENT RESPIMAT. Should you experience these symptoms, use caution when engaging in activities such as driving a car or operating appliances or other machines.

Do not use COMBIVENT RESPIMAT more often than your doctor has directed. Deaths have been reported with similar inhaled medicines in asthma patients who use the medicine too much. Seek medical attention if your treatment with COMBIVENT RESPIMAT becomes less effective for symptomatic relief, your symptoms become worse, and/or you need to use the product more frequently than usual.

Allergic reactions may occur, including itching, swelling of the face, lips, tongue, or throat (involving difficulty in breathing or swallowing), rash, hives, bronchospasm (airway narrowing), or anaphylaxis. Some of these may be serious. If you experience any of these symptoms, stop taking COMBIVENT RESPIMAT at once and call your doctor or get emergency help.

Tell your doctor about all your medical conditions, especially if you have narrow-angle glaucoma, prostate or urinary problems, a history of heart conditions (such as irregular heartbeat, high blood pressure), thyroid disorder, or diabetes. Also tell your doctor if you are pregnant or nursing. Tell your doctor about all medicines you are taking, especially heart medications or drugs to treat depression.

The most common side effects reported with use of COMBIVENT RESPIMAT include infection of the ears, nose, and throat, runny nose, cough, bronchitis, headache, and shortness of breath.

Click here for full Prescribing Information and Patient Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
CL-CBR-100003

Terms and Conditions

Eligible commercially insured patients 18 years or older may pay as little as $10/month with a maximum savings up to $50/monthly prescription for up to 6 prescriptions per calendar year. Benefits not to exceed program expiration on 12/31/2020. If you live in Massachusetts, card expires on the earlier of June 30, 2019, or date AB-rated generic equivalent is available. One card per patient, not transferable, and cannot be combined with any other offer. Card not accepted in Veteran’s Affairs pharmacies. Program not health insurance. You must present this card to the pharmacist with your Combivent Respimat prescription to participate. Only valid for commercially insured patients in the 50 United States, territories, DC, and Puerto Rico. Not eligible if prescriptions are paid for in part/full by state or federally funded program(s), like Medicare Part D, Medicaid, Veteran’s Affairs, Dept. of Def., or TRICARE and where prohibited by law. Offer may change at any time, without notice.